Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Comparative pharmacokinetics of macrolides.

O G Nilsen1

  • 1Department of Pharmacology and Toxicology, Faculty of Medicine, University of Trondheim, Norway.

The Journal of Antimicrobial Chemotherapy
|November 1, 1987
PubMed
Summary

Roxithromycin, an erythromycin derivative, offers improved pharmacokinetic properties like higher serum concentrations and a longer half-life. This allows for lower daily doses and less frequent administration compared to erythromycin.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Inhibition of P-glycoprotein in Caco-2 cells: effects of herbal remedies frequently used by cancer patients.

Xenobiotica; the fate of foreign compounds in biological systems·2008
Same author

Single- and multiple-dose pharmacokinetics, kidney tolerability and plasma protein binding of tenoxicam in renally impaired patients and healthy volunteers.

Pharmacology & toxicology·2002
Same author

Prediction of in vivo metabolic clearance of 25 different petroleum hydrocarbons by a rat liver head-space technique.

Archives of toxicology·2000
Same author

Measurement of HPRT mutations in splenic lymphocytes and haemoglobin adducts in erythrocytes of Lewis rats exposed to ethylene oxide.

Mutation research·2000
Same author

Effect of lifelong nicotine inhalation on bone mass and mechanical properties in female rat femurs.

Calcified tissue international·1999
Same author

Short-term exposure of rodents to diesel exhausts: usefulness for studies of genotoxic and immunotoxic effects.

Chemico-biological interactions·1999

Area of Science:

  • Pharmacology
  • Medicinal Chemistry
  • Antibiotic Development

Background:

  • Erythromycin is a widely used antibiotic.
  • There is a continuous need for improved antibiotic agents with better pharmacokinetic profiles.
  • Development of novel erythromycin derivatives is an active area of research.

Purpose of the Study:

  • To evaluate the pharmacokinetic properties of roxithromycin, a new erythromycin derivative.
  • To compare the pharmacokinetics of roxithromycin with erythromycin.
  • To determine an optimal dosage regimen for roxithromycin.

Main Methods:

  • Synthesis of roxithromycin, an ether oxime derivative of erythromycin.
  • Pharmacokinetic studies comparing roxithromycin and erythromycin in humans.
  • Analysis of serum concentrations and elimination half-life.

Main Results:

  • Roxithromycin demonstrated higher serum concentrations than erythromycin at equimolar oral doses.
  • Roxithromycin has a significantly longer elimination half-life (approximately 12 hours) compared to erythromycin (2-3 hours).
  • Similar tissue distribution and antibiotic profiles were observed for both drugs.

Conclusions:

  • Roxithromycin exhibits superior pharmacokinetic properties compared to erythromycin.
  • The improved pharmacokinetics allow for lower daily doses and less frequent administration of roxithromycin (e.g., 150 mg every 12 hours).
  • Roxithromycin offers a potentially more convenient and effective therapeutic option due to its pharmacokinetic advantages.

Related Experiment Videos